Fundz

Heligenics reported raising $2.16 Million in an initial SEC Form D filing, from an offering of $2.16 Million

PRIVATEAug 23, 2022

Amount Raised

$2.16 Million

$2.16 Million sold, per SEC Form D (first sale Jun 9, 2022)

Round Type

Seed

Las VegasBiotechnology

Quick answer

Heligenics raised $2.16 Million in a Seed round, dated June 9, 2022. Heligenics is based in Las Vegas, Nevada, United States.

How much did Heligenics raise?
Heligenics raised $2.16 Million in a Seed round on June 9, 2022.
What does Heligenics do?
Heligenics is a life sciences company that has developed proprietary technology, which shows the impact of genetic mutations to revolutionize genetic testing and drug development for major diseases.
Where is Heligenics based and how big is it?
Heligenics is based in Las Vegas, Nevada, United States. Fundz records about 10 employees.
Who are the decision-makers at Heligenics?
Fundz holds 2 contacts at Heligenics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Heligenics that raised within 45 days of this round, from Fundz verified event records.

  • Embody raised $10M on July 23, 2022.
  • Flyte Aviation, Inc. raised $6.2M on July 22, 2022.
  • Leviathan Therapeutics raised $250K on July 22, 2022.
  • Flyte Aviation, Inc. raised $6.2M (Funding Round) on July 22, 2022.
  • Enzo Life Sciences raised $3M (Seed) on July 22, 2022.
  • MIRA Pharmaceuticals raised $625K (Seed) on July 22, 2022.

Who to call at Heligenics, and when

A new round usually means Heligenics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Heligenics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Heligenics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Heligenics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Heligenics

Location

10530 DISCOVERY DR

Las Vegas, Nevada, United States

About

Heligenics is a life sciences company that has developed proprietary technology, which shows the impact of genetic mutations to revolutionize genetic testing and drug development for major diseases. We are the first company to develop High Content Screening for Biologic Drugs, previously the mainstay for the development of small compound drugs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Heligenics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts2 people are listed at Heligenics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Heligenics's next move

See what Strategic adds

Heligenics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.